• Most Popular
  • Most Shared

Humana eyes acquisitions in complementary areas-WSJ

Mon Nov 23, 2009 12:12am EST

Stocks

   

Nov 23 (Reuters) - Health insurer Humana Inc (HUM.N) is looking for acquisitions in complementary areas to adapt to changing healthcare need, its Chief Executive Mike McCallister told the Wall Street Journal in an interview.

Stocks  |  Mergers & Acquisitions  |  Financials

The company is targeting areas such as managing expenditure on expensive specialty drugs and chronic diseases.

"If you look at the future in terms of where drug spending is going to be, specialty drugs are going to get very large," McCallister told the paper. "It's important for the company to have the right positioning on that, whether it's inside or outside."

Humana set off a political storm in September when it sent letters to its Medicare Advantage health insurance plan customers warning them about pending health reform legislation. [ID:nN21320651] (Reporting by Deepti Govind in Bangalore; Editing by Valerie Lee) ((deepti.govind@thomsonreuters.com; within U.S. +1 646 223 8780; outside U.S. +91 80 4135 5800; Reuters Messaging: deepti.govind.reuters.com@reuters.net))



More from Reuters

Photo

Euro zone holds intensive talks about Greek rescue

BERLIN/ATHENS (Reuters) - Euro zone countries were holding intensive talks on Wednesday about a possible financial rescue for debt-stricken Greece as civil servants staged the first major strike against Athens' crisis-driven austerity plan. | Video

 A protester marches next to a banner during an anti-government rally in Athens February 10, 2010. REUTERS/John Kolesidis
Analysis:

Will IMF step in on Greece?

Europe is loathe to turn to the International Monetary Fund to help bail out Greece but it may have little choice.  Full Article 

A worker drives a Toyota Motor Corp's newly assembled Prius hybrid vehicle onto a trailer near the company's plant in Toyota, central Japan February 9, 2010.REUTERS/Yuriko Nakao
Reuters Breakingviews:

Toyota's troubles in overdrive

The cost of Toyota's recall nightmare is nothing compared to the price of fixing its battered reputation.  Commentary